Neurology, Neurocritical Care

• 

  People

  • Primary Appointments

    • Bennett, Ellen Ruth, Adjunct Assistant Professor in the Department of Neurology
    • Chang, Cherylee Wai Jun, Professor of Neurology
    • Colton, Katharine Rose, Assistant Professor of Neurology
    • Graffagnino, Carmelo, Professor of Neurology
    • Kolls, Bradley Jason, Associate Professor of Neurology
    • Laskowitz, Daniel Todd, Professor of Neurology
    • Marrotte, Eric J, Adjunct Associate in the Department of Neurology
    • Sasannejad, Cina, Assistant Professor of Neurology
    • Shah, Shreyansh, Assistant Professor of Neurology
    • Van Wyck, David Wayne, Consulting Associate in the Department of Neurology
    • Wang, Haichen, Assistant Professor in Neurology
    • Xian, Ying, Adjunct Associate Professor in the Department of Neurology

  • Secondary Appointments

    • James, Michael Lucas, Associate Professor in Neurology
    • Komisarow, Jordan, Assistant Professor in the Department of Neurology
    • Naglee, Colleen Marie, Assistant Professor in Neurology
    • Southwell, Derek, Assistant Professor in Neurology
• 

  Administers Grant

  • A Multicenter, Double-Blind, Placedbo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG0002) on reducing Infarct volume in Acute Ischemic Stroke.
  • A Phase 1B/2. Multiccenter,Doubleblind Placebo-controlled, Randomized, Single-Ascending dose study to assess the safety, Pharmacokinetics and pharmacodynamics of DS-1040B in Subjects with Acute Ischemic Stroke.
  • A Phase 2,PlaceboControlled,Randomized,Double-Blind,Parallel-Arm Study to EvaluateEfficacy and Safety of BMS-986141For the Prevention of Recurrent Brain Infarction in Subjects receiving acetylsalicyclic acid(ASA)followingAcute Ischemic Stroke or TIA
  • A Randomized, Double-Blind, MultiNational Study to Prevent Major Vascular Events with Ticagrelor Compared to Aspirin (ASA) in Patients with Acute Ischaemic Stroke or TIA (SOCRATES)
  • ApoE-mimetic peptides protect against brain injury
  • Apolipoprotein E effect on the CNS immune response
  • Apolipoprotein E effecton the CNS immune response.
  • Assessment of Application Tools for Electroencephalography Leads and EEG Recording Equipment in the ICU.
  • Development of Brain Monitoring technology: Neurologic Injury Monitoring with Real-time Output Display (NIMROD)
  • Effects of rGDF11 on Functional Recovery Following Traumatic Brain Injury (TBI) in Mice
  • Extract of Erigeron breviscapus protects against brain injury in stroke
  • Eythropotien Peptides & Traumatic Brain Injury
  • Genetic variation, stress, and functional outcomes after stroke rehabilitation
  • IPA- Hana Dawson
  • Karyopharm Theapeutics Clinipace Project
  • Linearized apoE peptide mimetic is neuroprotective in acute cerebrovascular disease
  • Medically ill Patient Assessment of Rivaroxaban versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism RISK (MARINER)
  • Neuroprotective pentapeptide improves outcome after ischemic stroke and subarachnoid hemorrhage
  • Phase 1/2 A Multicenter, Controlled, Randomized, Open-Label, Dose Escalation, Safety. Tolerability and Pharmocokinetic Study Comparing EG-1962 and Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhage.
  • Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Efficacy and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal subarachnoid Hemorrhage
  • Prophylactic administration of CN-105 confers neuroprotection against acute brain injury
  • Proteo improves outcomes after closed head injury and subarachnoid hemorrhage
  • Randomized Double Blind Placebo-Controlled Parallel Group, MultiCenter Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Larg
  • Secondary Stroke Prevention Study comparing Dabigatran vs Acetylsalicylic Acid in patients with Embolic Stroke of Undetermined Source RE-SPECT ESUS
  • The Effect Of Apoe On Cholinergic Neuron Survival
  • Trangenic Mouse Model of Alzheimer's Disease
  • pH dependent neuroprotective agents improve outcome in murine SAH
  • rGDF11 improves outcomes after closed head injury and intracranial hemorrhage
  • same

Add data to my Website